Dr. Gootenberg is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
6915 Breezewood Ter
Rockville, MD 20852Phone+1 301-881-0818Fax+1 301-881-0819
Education & Training
- National Capital ConsortiumFellowship, Pediatric Hematology/Oncology, 1978 - 1981
- Boston Children’s Hospital/Boston Medical CenterResidency, Pediatrics, 1975 - 1978
- Albert Einstein College of MedicineClass of 1975, MD, AOA
- Harvard UniversityAB, Biochemical Sciences, Mgna cum Laude, 1967 - 1971
Certifications & Licensure
- MD State Medical License 1981 - 2026
- VA State Medical License 1987 - 2014
- DC State Medical License 1981 - 2013
- American Board of Pediatrics Pediatrics
- American Board of Pediatrics Pediatric Hematology-Oncology
Publications & Presentations
PubMed
- 171 citationsFDA Drug Approval Summary: Pegaspargase (Oncaspar®) for the First-Line Treatment of Children with Acute Lymphoblastic Leukemia (ALL)Patricia Anne Dinndorf, Joseph E. Gootenberg, Martin H. Cohen, Patricia Keegan, Richard Pazdur
The Oncologist. 2007-08-01 - 34 citationsEribulin Mesylate for the Treatment of Patients with Refractory Metastatic Breast Cancer: Use of a “Physician's Choice” Control Arm in a Randomized Approval TrialMartha Donoghue, Steven Lemery, Weishi Yuan, Kun He, Rajeshwari Sridhara
Clinical Cancer Research. 2012-03-15 - 318 citationsAdults and children with small non-cleaved-cell lymphoma have a similar excellent outcome when treated with the same chemotherapy regimen.Ian Magrath, Melissa Adde, Aziza T. Shad, David Venzon, Nita L. Seibel
Journal of Clinical Oncology. 1996-03-01
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: